CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology – BioSpace

• July 8, 2025
• 0 Comments
• Less than a minute
• 35 Views
• 3 months ago